BioSpace News Archive

Business

Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024

Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced that it has scheduled a conference call to discuss third quarter of fiscal year 2024 financial results on Wednesday, May 15, 2024, at 5:00pm ET.

May 8, 2024
·
3 min read
Business

Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update

Pharvaris reported financial results for the first quarter ended March 31, 2024, and provided a business update.

May 8, 2024
·
8 min read
Business

Context Therapeutics Reports First Quarter 2024 Operating and Financial Results

Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the first quarter ended March 31, 2024, and reported on recent business highlights.

May 8, 2024
·
6 min read
Business

Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the first quarter and provided a business update.

May 8, 2024
·
18 min read
Business

Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities

Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, reported financial results for the first quarter ended March 31, 2024.

May 8, 2024
·
12 min read
Business

Myomo Reports First Quarter 2024 Financial Results

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.

May 8, 2024
·
14 min read
Business

Exact Sciences Announces First-Quarter 2024 Results

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $638 million for the first quarter ended March 31, 2024, compared to $602 million for the same period of 2023.

May 8, 2024
·
21 min read
Business

Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.

May 8, 2024
·
12 min read
Business

Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2024, along with recent product highlights and corporate updates.

May 8, 2024
·
18 min read
Business

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024.

May 8, 2024
·
17 min read